Alternative buffer management strategies to achieve downstream process improvements
PharmaTech
JANUARY 28, 2024
Buffers are used in great quantities when producing monoclonal antibodies (mAbs), and many biopharmaceutical companies — even large ones — do not have the processing capacity or infrastructure in-house to handle these large volumes.
Let's personalize your content